Adagene Expands Scientific and Strategic Advisory Board with Appointment of David Gandara, M.D.
- Dr. Gandara, Professor and Senior Advisor to the Thoracic Oncology Program at University of California Davis, brings deep expertise...
Year: 2022
Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance
-- Fourth Quarter 2021 net sales for UPNEEQ grew by approximately 41% to $3.1 million compared to the third quarter...
PLx Pharma Inc. Appoints Janet Barth to Newly Created Role of Vice President, Investor Relations & Corporate Communications
SPARTA, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage...
HEXO Provides Update on “The Path Forward”; Announces Cost Savings Initiatives
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 11, 2021...
Acutus Medical Announces Restructuring and Preliminary, Unaudited Fourth Quarter and Full Year 2021 Revenue
CARLSBAD, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management...
Bavarian Nordic Appoints Russell Thirsk as new Chief Operating Officer
COPENHAGEN, Denmark, January 19, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today the appointment of Russell Thirsk as Executive...
Mainz Biomed Engages DCN Dx to Support Clinical Study Evaluating Novel mRNA Biomarkers for Potential Integration into ColoAlert
Results of European study potentially incorporated into U.S. regulatory strategy for FDA approval Opportunity for ColoAlert to become the gold...
Second positive Phase 3 Dupixent® (dupilumab) trial confirms significant improvements for patients with prurigo nodularis
Second positive Phase 3 Dupixent® (dupilumab) trial confirms significant improvements for patients with prurigo nodularis Dupixent is the first and...
Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook
REGULATED INFORMATION Recruitment for ALLOB tibial facture Phase IIb study ongoing and on schedule to release topline data in Q1...
Awakn Life Sciences Signs MOU with Maps
Agreement to Explore a Partnership for MDMA-Assisted Therapy for Treatment of Alcohol Use Disorder in EuropeToronto, Ontario--(Newsfile Corp. - January...
Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board
Oakville, Ontario--(Newsfile Corp. - January 19, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
CareView Communications Executes Agreement With a Large For-Profit Health System Division
LEWISVILLE, Texas--(BUSINESS WIRE)--CareView Communications, Inc. (“CareView” or the “Company”) (OTCQB: CRVW), a technology provider to the healthcare industry, today announced...
Ceptur Therapeutics Launches with $75M Series A Financing to Advance RNA Therapeutics Based on Proprietary U1 Adaptor Technology
Financing co-led by venBio Partners & Qiming Venture Partners USA with participation from strong syndicate of new and existing investors...
Tempo Automation, Inc. Secures $200 Million Convertible Note Financing Led by Oaktree
SAN FRANCISCO--(BUSINESS WIRE)--Tempo Automation, (“Tempo” or the “Company”), a leading software-accelerated electronics manufacturer, and ACE Convergence Acquisition Corp. (“ACE”) (Nasdaq:...
Abivax’s Phase 1/2 Clinical Study Results of ABX196 in Liver Cancer to be Presented on Jan. 21, at ASCO GI Cancers Symposium 2022
ABX196 phase 1/2 study results for the treatment of hepatocellular carcinoma (HCC) were selected for a presentation at the ASCO...
Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who’ve Exhausted All Approved Therapies
GENEVA, SWITZERLAND / ACCESSWIRE / January 19, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...
Asia Green Biotechnology Corp. Early Warning Report Issued Pursuant to National Instrument 62–103
CALGARY, AB / ACCESSWIRE / January 18, 2022 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) reports...
Phreesia Life Sciences’ PatientInsights Named one of PM360’s 2021 Most Innovative Services
RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named PatientInsights, Phreesia Life...
Novo Integrated Sciences Reports First Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #Benzinga--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and...
Cohen Veterans Network Launches Innovative Diversity Training Available to Mental Health Providers at No-Cost
STAMFORD, Conn., Jan. 18, 2022 /PRNewswire/ -- Cohen Veterans Network (CVN), a not-for-profit philanthropic organization that serves post-9/11 veterans, service members...